P293 eHealth: Individualisation of MMX mesalamine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis

Pedersen, Natalia; Burisch, Johan; Martinsen, L.; Bennedsen, Mette; Thielsen, Peter; Bell, Sally; Végh, Zsuzsanna; Haaber, Anne; Ďuricová, Dana; Jess, Tine; Langholz, Ebbe; Munkholm, Pia

doi:10.1016/s1873-9946(14)60414-1

Cited by 12 publications

(17 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hypothetically, the extent of diagnostic delay in Asian countries might be longer in comparison to high‐prevalent regions in West due to lack of disease awareness. However, existing studies from Asia reported a duration of diagnostic delay comparable to that in European cohort studies . Future studies are required to clarify whether true differences in disease presentation exist between East and West.…”

Section: Clinical Features Of Ibdmentioning

confidence: 93%

The epidemiology of inflammatory bowel disease: East meets west

Mak

Zhao

et al. 2019

J of Gastro and Hepatol

422

291

View full text Add to dashboard Cite

The incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade to become a global disease. The increasing number of studies on the incidence and course of IBD in East has enabled us to explore East versus West differences in the epidemiology of IBD which could enhance our understanding of the heterogeneity of the disease and eventually assist in the discovery of novel therapeutic targets and design of preventive strategies. Comparison of population‐based data in East and West reveals that the incidence of IBD has risen rapidly in East while plateauing in West. Furthermore, the clinical presentation and course of IBD differs between East and West with more patients in East presenting with complicated disease. Considering the scarcity of population‐based data from East and the lack of studies with long durations of follow‐up, it remains to be clarified whether these differences reflect true differences in disease presentation. The effects of genetic and environmental risk factors contributing to IBD also differ between Eastern and Western populations. Considering the differential effects of genetic and environmental risk factors in East and West, future studies should seek to discover novel genetic and environmental risk factors which might specifically apply to eastern populations. In this narrative review, we compare the epidemiology of IBD between eastern and western countries by summarizing evidence from population‐based cohort studies in the last ten years. Furthermore, we look at differences in genetic susceptibility and environmental triggers of IBD between East and West.

show abstract

Section: Clinical Features Of Ibdmentioning

confidence: 93%

The epidemiology of inflammatory bowel disease: East meets west

Mak

Zhao

et al. 2019

J of Gastro and Hepatol

422

291

View full text Add to dashboard Cite

show abstract

“…This approach was shown to empower patients and decrease relapse duration. 9,10 Similarly, individualization of infliximab dosing in patients with Crohn's disease (CD) was reported to be practical and feasible. 11 A study evaluating another home tele-management system in UC (UC-HAT) did not show significant differences in disease activity and quality of life between users and control subjects, and more than one-third of the patients discontinued participation.…”

mentioning

confidence: 99%

Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies

Deen

Jong

Parekh

et al. 2016

Clinical Gastroenterology and Hepatology

View full text Add to dashboard Cite

show abstract

“…The Constant Care© application combines disease monitoring with an algorithm that actively provides treatment advice and is able to aid patients in treatment adherence, as well as individual dosing of medication. It consists of a patient education package (eLearning and educational video‐clips) and a web‐based disease monitoring package.…”

Section: Tools For Telemonitoringmentioning

confidence: 99%

Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease

Ankersen

Carlsen

Marker

et al. 2017

J of Gastro and Hepatol

View full text Add to dashboard Cite

Health‐care systems around the world are facing increasing costs. Non‐adherent, chronically ill patients are one such expense incurred by health‐care providers. Web‐based home‐monitoring of patients—or eHealth—has been shown to increase adherence to medical therapy, facilitate contact between patients and health‐care professionals, and reduce time to remission for patients with inflammatory bowel disease (IBD). Web‐based treatment is a supportive tool for the health‐care provider in an out‐patient clinic. eHealth web‐programs, such as the Constant Care application, visualize disease activity in a traffic light system and empower patients to screen for disease activity, enabling them to respond appropriately to their symptoms. The eHealth screening procedure for monitoring both pediatric and adult IBD patients is based on a self‐obtained symptom score, together with a fecal biomarker for inflammation (fecal calprotectin) that the patients can measure independently using their smart phone, providing both patient and physician with an immediate disease status that they can react to instantaneously. Likewise, web applications for IBD patients, web applications for irritable bowel syndrome (IBS) patients and also IBD patients with co‐existing IBS, have proven valuable for monitoring and treating IBS symptoms with a diet low in fermentable oligo‐, di‐, monosaccharides and polyols (low‐FODMAP diet). With careful disease monitoring via the web application and increased patient adherence, eHealth might be capable of improving the natural disease course of IBD and IBS.

show abstract

P293 eHealth: Individualisation of MMX mesalamine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis

Cited by 12 publications

References 0 publications

The epidemiology of inflammatory bowel disease: East meets west

The epidemiology of inflammatory bowel disease: East meets west

Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies

Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease

Contact Info

Product

Resources

About